HIV and hepatitis C virus: special concerns for patients with cirrhosis

Area of Science:

• Infectious Diseases
• Hepatology
• Virology

Background:

• Liver disease is a leading cause of illness and death in human immunodeficiency virus (HIV)-infected individuals, particularly due to chronic viral hepatitis.
• Hepatitis C virus (HCV) disease progression, drug-induced liver injury, and direct HIV effects contribute to liver morbidity.
• End-stage liver disease and hepatocellular carcinoma are common in HIV patients with advanced liver disease.

Purpose of the Study:

• To highlight the critical need for managing liver disease in HIV-infected patients.
• To guide infectious diseases physicians on assessing advanced fibrosis and screening for complications.
• To emphasize the importance of hepatocellular carcinoma screening in this population.

Main Methods:

• Review of current literature on HIV and liver disease interactions.
• Analysis of factors contributing to liver-related morbidity and mortality.
• Guidelines for clinical assessment and patient management.

Main Results:

• Chronic viral hepatitis is responsible for over 80% of liver-related deaths in HIV patients.
• HIV accelerates HCV disease, increasing risks of hepatotoxicity and end-stage liver disease.
• Hepatocellular carcinoma is a frequent complication requiring proactive screening.

Conclusions:

• Infectious diseases physicians must be adept at assessing liver fibrosis in HIV patients.
• Timely referral for variceal screening and hepatocellular carcinoma surveillance is essential.
• Integrated management of HIV and liver disease is critical for improving patient outcomes.